$VICR

VINCIARELLI PATRIZIO sold $515K of VICR

VINCIARELLI PATRIZIO (Chairman and CEO) sold 1,673 shares of VICOR CORP (VICR) at $307.69 ($0.51M total) on 2026-06-04 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · VINCIARELLI PATRIZIO
Published Jun 5, 2026, 4:10 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 5, 2026, 4:21 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VICR
Neutral
medium confidence
Mentioned
$VICR
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

This provides a fresh, time-stamped insider trading datapoint, but it does not introduce new fundamentals (earnings, guidance, deals, litigation, or regulatory actions).

02

Market read

Traders may briefly reassess sentiment around VICR due to insider selling, but the 10b5-1 framing suggests limited fundamental signal.

03

What to watch

The filing does not disclose reasons for the sale; traders should compare with prior insider activity and remaining holdings rather than extrapolate.

Relevance 6/10Novelty 5/10Timing: Filed 2026-06-05 for a sale executed 2026-06-04

Background

The article is an SEC Form 4 insider transaction disclosure for Vicor Corp, showing an officer/director/10% owner sale under a 10b5-1 plan.

Company-level read

Ticker impact

$VICRNeutralMedium confidence
Context

VICR CEO/Chairman sold $514,767 of VICR stock via an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven rather than fundamental.

Evidence & confidence

Form 4 provides a specific sale datapoint, but it is explicitly under a pre-arranged 10b5-1 plan and contains no new operating/financial catalyst.

Market effects

Minimal; this is company-specific insider activity with no stated sector-wide development.

None indicated.

None indicated.

Counterpoint

Because the sale was executed under a pre-arranged 10b5-1 plan, it may reflect routine diversification rather than bearish expectations.

Key entities

  • VICOR CORP

    Subject of the Form 4 insider transaction disclosure.

  • VINCIARELLI PATRIZIO

    Chairman and CEO who sold shares via open-market sale under a 10b5-1 plan.

Related articles

$VICRMedAI 8/10

Vicor (VICR) Q2 2026 Earnings Call Transcript

Vicor’s Q2 2026 earnings call reported product and royalty revenue of $143.4M, up 26.9% sequentially and 1.6% year over year. Advanced products revenue rose to $94.2M. Net income was $49.8M, GAAP diluted EPS $1.40, and cash was $453.6M. The company guided for nearly 10% Q3 revenue growth and over $600M 2026 revenue, citing capacity increases and licensing assumptions.

$VICRMed

Vicor Corp (VICR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth

Vicor Corp said a new license agreement will bring $5 million quarterly payments in year one and $10 million in year two, with $15 million contributing to Q2 revenue and additional revenue recognition expected in Q3 and subsequent quarters. Management also discussed fab capacity expansion to support a $2.5 billion revenue goal and said backlog growth stems mainly from existing customer demand.

$VICRMed

VICOR CORP (VICR): Results of Operations and Financial Condition

VICOR CORP (VICR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d115827dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE FINANCIAL NEWS BRIEF July 21, 2026 For Immediate Release Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026 Andover, Mass., July 21, 2026 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ: